Which Orthopaedic Patients Are Infected with Gram-negative Non-fermenting Rods?
Omid Jamei, Shpresa Gjoni, Besa Zenelaj...
https://pubmed.ncbi.nlm.nih.gov/28529866/Actively Recruiting
Led by Balgrist University Hospital · Updated on 2024-12-02
1100
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the use of broad-spectrum antibiotic prophylaxis in specific orthopedic surgeries, such as tumor surgeries, infected wound debridements, and open fractures, where there is a high risk of surgical site infections SSIs caused by antibiotic-resistant bacteria. The study explores whether adding vancomycin and gentamicin to standard prophylaxis can better prevent infections, especially in cases involving resistant pathogens or ongoing antibiotic treatments. This phase 3 trial focuses on improving infection control in these high-risk surgical situations. Participants in the trial are randomly assigned to receive either standard antibiotic prophylaxis, which includes one to three doses of cefuroxime or alternatives like vancomycin or clindamycin in case of allergies, or an additional single-shot broad-spectrum prophylaxis with vancomycin and gentamicin given intravenously before surgery. The study allows for continued therapeutic antibiotic use if applicable and includes various surgical conditions such as tumor surgery, spine surgery with specific risk factors, and contaminated wounds. Each surgery is treated as a separate event, and patients undergoing multiple surgeries may receive different prophylaxis each time. During the study, participants will have daily visits starting with enrollment on Day 1, followed by an end-of-treatment visit around Day 14, and a test-of-cure surgical control visit around Day 42. A telephone follow-up occurs after one year for implant-related surgeries. Researchers will monitor surgical site infections at 6 weeks or 1 year depending on implant use, track antibiotic-resistant pathogens, assess changes in antibiotic therapies, record adverse events, and evaluate infection rates and bacterial colonization. The study aims to provide detailed insights into infection prevention and antimicrobial resistance in orthopedic surgery.
CONDITIONS
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
I
Ilker Uçkay, Professor
M
Mazda Farshad, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Balgrist University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 1 (surgery day)
Participants receive perioperative antibiotic prophylaxis with either standard antibiotic doses or an additional broad-spectrum single-shot regimen during their orthopedic surgery.
1 enrollment visit (in-person) on Day 1 and daily study visits during hospital stay
Duration - Up to 1 year post-surgery
Participants attend follow-up visits to assess surgical site infections and other outcomes, including clinical surgical control and telephone follow-up for implant-related surgeries.
1 end-of-treatment visit around Day 14, 1 test-of-cure visit around Day 42, and 1 telephone follow-up at 1 year (implant-related surgeries only)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Omid Jamei, Shpresa Gjoni, Besa Zenelaj...
https://pubmed.ncbi.nlm.nih.gov/28529866/Lydia Wuarin, Mohamed Abbas, Stephan Harbarth...
https://pubmed.ncbi.nlm.nih.gov/31851708/Daniel Müller, Dominik Kaiser, Kati Sairanen...
https://pubmed.ncbi.nlm.nih.gov/31966954/Ilker Uçkay, Hagen Bomberg, Markus Risch...
https://pubmed.ncbi.nlm.nih.gov/38243311/I Uçkay, P Hoffmeyer, D Lew...
https://pubmed.ncbi.nlm.nih.gov/23414705/Balgrist University Hospital
Lead Sponsor